Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kaneka Nutrients is a premier developer and manufacturer of science-based nutritional ingredients, serving as a key division of the global chemical and biotech leader Kaneka Corporation. The company is most distinguished as the world's leading producer of Ubiquinol, the active, non-oxidized form of Coenzyme Q10, which is manufactured through a proprietary yeast fermentation process. Beyond its flagship Ubiquinol product, Kaneka Nutrients offers a diverse portfolio including the Floradapt probiotic line and MenaQ7 Vitamin K2, following the strategic acquisition of NattoPharma. Their ingredients are utilized globally by dietary supplement and functional food manufacturers to support cardiovascular health, bone density, and metabolic function. With a commitment to pharmaceutical-grade quality and extensive clinical validation, Kaneka Nutrients provides high-purity solutions backed by over three decades of research and development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kaneka Nutrients.